Indomobil Sukses Internasional Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Indomobil Sukses Internasional Tbk. trades at Rp840 (market cap 3.34T, 162.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Indomobil Sukses Internasional Tbk. is far larger — about 20× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Indomobil Sukses Internasional Tbk. is more actively traded (162.9K versus 96.7K). Which is the better fit depends on your goals.
| IMAS | OBAT | |
|---|---|---|
Market Cap | 3.34T | 167.37B |
Volume | 162.9K | 96.7K |
Lot | 1.63K | 967 |
Turnover | 137.15M | 23.82M |
Average Price | 841.95 | 246.34 |
Value | 137.15M | 23.82M |
Indicative Equilibrium Price | 840 | 248 |
Indicative Equilibrium Volume | 4 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indomobil Sukses International Tbk (the Company) was initially established as a result of the merger between PT Indomulti Inti Industri Tbk (IMII) and PT Indomobil Investment corporation (IIC). The Company’s articles of association has been amended from time to time, most recently on June 30, 1999 in connection with the Company’s plans to offer shares with pre-emptive right. The Ministry of Justice has approved the amendment on July 5, 1999.
Read more on IMAS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →